{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:04:47Z","timestamp":1790809487271,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Youde Zhongbang Technology Co., Ltd.","award":["Grant No. ZYHZ-2016-01."],"award-info":[{"award-number":["Grant No. ZYHZ-2016-01."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06211-y","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:34:51Z","timestamp":1783431291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic dysfunction-associated steatotic liver disease with coronary plaque vulnerability and prognosis in patients with acute coronary syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Muhan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranzun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-4666","authenticated-orcid":false,"given":"Jianling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"6211_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"6211_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"issue":"23","key":"6211_CR3","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.3390\/jcm14238361","volume":"14","author":"NA Ciurea","year":"2025","unstructured":"Ciurea NA, Pantea CM, Grama P, Kosovski IB, Farella I, et al. Ten-Year Atherosclerotic Cardiovascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Separate Analyses from Romanian and Italian Cohorts Integrating Metabolic, Hepatic, and Gut-Liver Axis Markers. J Clin Med. 2025;14(23):8361.","journal-title":"J Clin Med"},{"issue":"11","key":"6211_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","volume":"10","author":"C Celsa","year":"2025","unstructured":"Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, et al. Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(11):998\u20131012.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"6211_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol. 2024;23(1):346.","journal-title":"Cardiovasc Diabetol"},{"key":"6211_CR6","doi-asserted-by":"publisher","first-page":"120495","DOI":"10.1016\/j.atherosclerosis.2025.120495","volume":"409","author":"C Ratti","year":"2025","unstructured":"Ratti C, Malaguti M, Emanuele D, Bellasi A, Sanna G. Understanding MASLD - from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis. 2025;409:120495.","journal-title":"Atherosclerosis"},{"issue":"10","key":"6211_CR7","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.14309\/ajg.0000000000003274","volume":"120","author":"HH Lee","year":"2025","unstructured":"Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, et al. Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study. Am J Gastroenterol. 2025;120(10):2321\u20139.","journal-title":"Am J Gastroenterol"},{"key":"6211_CR8","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","volume":"65","author":"JH Moon","year":"2023","unstructured":"Moon JH, Jeong S, Jang H, Koo BK, Kim W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023;65:102292.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"6211_CR9","doi-asserted-by":"publisher","first-page":"11845","DOI":"10.1038\/s41598-023-38675-9","volume":"13","author":"JJ Cao","year":"2023","unstructured":"Cao JJ, Shen L, Nguyen J, Rapelje K, Porter C, et al. Accuracy and limitation of plaque detection by coronary CTA: a section-to-section comparison with optical coherence tomography. Sci Rep. 2023;13(1):11845.","journal-title":"Sci Rep"},{"issue":"2","key":"6211_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12928-024-01080-8","volume":"40","author":"K Fujii","year":"2025","unstructured":"Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, et al. Expert consensus statement for quantitative measurement and morphologic assessment of optical coherence tomography: update 2025. Cardiovasc Interv Ther. 2025;40(2):226\u201333.","journal-title":"Cardiovasc Interv Ther"},{"issue":"3","key":"6211_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","volume":"41","author":"F Prati","year":"2020","unstructured":"Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41(3):383\u201391.","journal-title":"Eur Heart J"},{"key":"6211_CR12","doi-asserted-by":"publisher","first-page":"90536","DOI":"10.3389\/fcvm.2022.905363","volume":"9","author":"C Xue","year":"2022","unstructured":"Xue C, Chen Q, Bian L, Yin Z, Xu Z, et al. The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study. Front Cardiovasc Med. 2022;9:90536.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"6211_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jacc.2025.04.070","volume":"86","author":"M Covani","year":"2025","unstructured":"Covani M, Niccoli G, Fujimoto D, Scalamera R, Vergallo R, et al. Plaque vulnerability and cardiovascular risk factor burden in acute coronary syndrome: An optical coherence tomography analysis. J Am Coll Cardiol. 2025;86(2):77\u201389.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"6211_CR14","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.3748\/wjg.v20.i23.7392","volume":"20","author":"SS Lee","year":"2014","unstructured":"Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(23):7392\u2013402.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"6211_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"key":"6211_CR16","doi-asserted-by":"publisher","first-page":"e073843","DOI":"10.1136\/bmj-2022-073843","volume":"381","author":"CP Gale","year":"2023","unstructured":"Gale CP, Stocken DD, Aktaa S, Reynolds C, Gilberts R, et al. Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial. BMJ. 2023;381:e073843.","journal-title":"BMJ"},{"issue":"12","key":"6211_CR17","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.7150\/jca.24872","volume":"9","author":"L Lin","year":"2018","unstructured":"Lin L, Zhao J, Hu J, Zou G, Huang F, et al. Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance. J Cancer. 2018;9(12):2140\u20136.","journal-title":"J Cancer"},{"issue":"12","key":"6211_CR18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"6211_CR19","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, et al. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19\u201340.","journal-title":"Diabetes Care"},{"issue":"38","key":"6211_CR20","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"12","key":"6211_CR21","first-page":"1376","volume":"22","author":"T Kubo","year":"2021","unstructured":"Kubo T, Ino Y, Mintz GS, Shiono Y, Shimamura K, et al. Optical coherence tomography detection of vulnerable plaques at high risk of developing acute coronary syndrome. Eur Heart J Cardiovasc Imaging. 2021;22(12):1376\u201384.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"6211_CR22","doi-asserted-by":"publisher","first-page":"e23191","DOI":"10.1016\/j.heliyon.2023.e23191","volume":"9","author":"Z Qin","year":"2023","unstructured":"Qin Z, Yu L, Zhang Y, Xu Q, Li C, et al. Coronary artery calcification and plaque stability: an optical coherence tomography study. Heliyon. 2023;9(12):e23191.","journal-title":"Heliyon"},{"issue":"10","key":"6211_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/00033197221087778","volume":"73","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhao X, Zhou P, Liu C, Liao Z, et al. High-Risk Culprit Plaque Predicts Cardiovascular Outcomes Independently of Plaque Rupture in ST-Segment Elevation Myocardial Infarction: Insight From Optical Coherence Tomography. Angiology. 2022;73(10):946\u201355.","journal-title":"Angiology"},{"issue":"12","key":"6211_CR24","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.amjcard.2010.01.346","volume":"105","author":"H Kitabata","year":"2010","unstructured":"Kitabata H, Tanaka A, Kubo T, Takarada S, Kashiwagi M, et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease. Am J Cardiol. 2010;105(12):1673\u20138.","journal-title":"Am J Cardiol"},{"issue":"15","key":"6211_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/CIRCULATIONAHA.124.071855","volume":"151","author":"J Dai","year":"2025","unstructured":"Dai J, Zhao J, Xu X, Chen Y, Sun S, et al. Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology? Circulation. 2025;151(15):1098\u2013110.","journal-title":"Circulation"},{"issue":"9","key":"6211_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jcin.2015.02.026","volume":"8","author":"T Higuma","year":"2015","unstructured":"Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, et al. A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2015;8(9):1166\u201376.","journal-title":"JACC Cardiovasc Interv"},{"key":"6211_CR27","doi-asserted-by":"publisher","first-page":"1663408","DOI":"10.3389\/fcvm.2025.1663408","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Hua X, Hu R, Wan J, You Y, et al. Relationship between red cell distribution width-to-albumin ratio and major adverse cardiovascular events among individuals with acute myocardial infarction. Front Cardiovasc Med. 2025;12:1663408.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6211_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12933-024-02268-1","volume":"23","author":"T Nishihara","year":"2024","unstructured":"Nishihara T, Miyoshi T, Nakashima M, Miki T, Toda H, et al. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease. Cardiovasc Diabetol. 2024;23(1):167.","journal-title":"Cardiovasc Diabetol"},{"issue":"24","key":"6211_CR29","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, et al. Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation. 2018;137(24):2635\u201350.","journal-title":"Circulation"},{"key":"6211_CR30","doi-asserted-by":"publisher","first-page":"1670418","DOI":"10.3389\/fcvm.2025.1670418","volume":"12","author":"Z Sun","year":"2026","unstructured":"Sun Z, Hui J, Wang Y, Wang J, He R, et al. Serum uric acid level and prognosis of acute coronary syndrome: a systematic review and dose-response meta-analysis. Front Cardiovasc Med. 2026;12:1670418.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"6211_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/eurheartj\/ehae927","volume":"46","author":"G CLAESSEN","year":"2025","unstructured":"Claessen G, Eijsvogels TMH, Albert CM, et al. Coronary atherosclerosis in athletes: emerging concepts and preventive strategies [J]. Eur Heart J. 2025;46(10):890\u2013903.","journal-title":"Eur Heart J"},{"issue":"1","key":"6211_CR32","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1038\/s41598-023-34462-8","volume":"13","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zheng M, Lei H, Jiang Z, Chen Y, et al. A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern. Sci Rep. 2023;13(1):7224.","journal-title":"Sci Rep"},{"issue":"2","key":"6211_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4070\/kcj.2025.0212","volume":"56","author":"MG Suresh","year":"2026","unstructured":"Suresh MG, Mohamed S, Geetha HS, Prabhu S, Trivedi N, et al. Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. Korean Circ J. 2026;56(2):103\u201330.","journal-title":"Korean Circ J"},{"issue":"11","key":"6211_CR34","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/biomedicines11112897","volume":"11","author":"J Vekic","year":"2023","unstructured":"Vekic J, Stromsnes K, Mazzalai S, Zeljkovic A, Rizzo M, et al. Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk. Biomedicines. 2023;11(11):2897.","journal-title":"Biomedicines"},{"issue":"11","key":"6211_CR35","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/CIRCRESAHA.123.321563","volume":"132","author":"MF Linton","year":"2023","unstructured":"Linton MF, Yancey PG, Tao H, Davies SS. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy. Circ Res. 2023;132(11):1521\u201345.","journal-title":"Circ Res"},{"issue":"9","key":"6211_CR36","doi-asserted-by":"publisher","first-page":"e14188","DOI":"10.1111\/eci.14188","volume":"54","author":"O De Filippo","year":"2024","unstructured":"De Filippo O, Di Pietro G, Nebiolo M, Ribaldone DG, Gatti M, et al. Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis. Eur J Clin Invest. 2024;54(9):e14188.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"6211_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00535-018-1516-5","volume":"54","author":"HE Park","year":"2019","unstructured":"Park HE, Lee H, Choi SY, Kwak MS, Yang JI, et al. Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter. J Gastroenterol. 2019;54(3):271\u201380.","journal-title":"J Gastroenterol"},{"issue":"3","key":"6211_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5114\/ceh.2023.130744","volume":"9","author":"AE Platek","year":"2023","unstructured":"Platek AE, Szymanska A. Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor. Clin Exp Hepatol. 2023;9(3):187\u201392.","journal-title":"Clin Exp Hepatol"},{"issue":"8","key":"6211_CR39","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/biomedicines13082004","volume":"13","author":"M Romeo","year":"2025","unstructured":"Romeo M, Silvestrin A, Senese G, Di Nardo F, Napolitano C, et al. From Traditional to Trained Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomedicines. 2025;13(8):2004.","journal-title":"Biomedicines"},{"issue":"8","key":"6211_CR40","first-page":"1758","volume":"13","author":"Y Dimitroglou","year":"2023","unstructured":"Dimitroglou Y, Aggeli C, Theofilis P, Tsioufis P, Oikonomou E, et al. Novel anti-inflammatory therapies in coronary artery disease and acute coronary syndromes. Life (Basel). 2023;13(8):1758.","journal-title":"Life (Basel)"},{"issue":"2","key":"6211_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/cells14020144","volume":"14","author":"MP Donadini","year":"2025","unstructured":"Donadini MP, Calcaterra F, Romualdi E, Ciceri R, Cancellara A, et al. The link between venous and arterial thrombosis: is there a role for endothelial dysfunction? Cells. 2025;14(2):144.","journal-title":"Cells"},{"issue":"160","key":"6211_CR42","first-page":"9","volume":"248","author":"VH Rao","year":"2016","unstructured":"Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK. Tumor necrosis factor-\u03b1 regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis. 2016;248:160\u20139.","journal-title":"Atherosclerosis"},{"key":"6211_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jcdd11030077","volume":"11","author":"RI Orzan","year":"2024","unstructured":"Orzan RI, Gligor RI, Agoston R, Cionca C, Zlibut A, et al. Metabolic dysfunction associated liver disease in patients undergoing coronary computed tomography angiography. J Cardiovasc Dev Dis. 2024;11(3):77.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"6211_CR44","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1038\/s41598-025-89293-6","volume":"15","author":"GE Chung","year":"2025","unstructured":"Chung GE, Yu SJ, Yoo JJ, Cho Y, Lee KN, et al. Metabolic dysfunction-associated steatotic liver disease increases cardiovascular disease risk in young adults. Sci Rep. 2025;15(1):5777.","journal-title":"Sci Rep"},{"issue":"1","key":"6211_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12872-024-03880-5","volume":"24","author":"R Shi","year":"2024","unstructured":"Shi R, Li X, Sun K, Liu F, Kang B, et al. Association between severity of nonalcoholic fatty liver disease and major adverse cardiovascular events in patients assessed by coronary computed tomography angiography. BMC Cardiovasc Disord. 2024;24(1):267.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"6211_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcin.2025.11.021","volume":"19","author":"PEP Carvalho","year":"2026","unstructured":"Carvalho PEP, Antunes VLJ, Bittar de Pontes V, Gomes WF, Polachini Assunes Goncalves B, et al. IVUS, OCT, or angiography as guidance for PCI in complex coronary artery lesions: network meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2026;19(1):31\u201343.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"6211_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12880-025-02000-9","volume":"25","author":"JJ Wang","year":"2025","unstructured":"Wang JJ, Huang XL, Guo Y, Tao XW, Zeng MS, et al. Association of metabolic dysfunction-associated fatty liver disease with coronary CT angiography-derived plaque characteristics and cardiovascular events. BMC Med Imaging. 2025;25(1):452.","journal-title":"BMC Med Imaging"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06211-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06211-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06211-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:23:29Z","timestamp":1790807009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06211-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6211"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06211-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Affiliated Hospital of Zunyi Medical University. All patients signed a written informed consent form to participate in the study prior to any procedures.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"856"}}